Search

Search Constraints

You searched for: Author/Creator Moghal, Nadeem

Search Results

1. BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer. (August 2020)

2. EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft models. (July 2020)

5. Molecular heterogeneity of non‐small cell lung carcinoma patient‐derived xenografts closely reflect their primary tumors. Issue 3 (7th November 2016)